Calcium channel blocker nasal spray treats paroxysmal supraventricular tachycardia

The calcium channel blocker etripamil (Cardamyst), a nasal spray, has been approved for treatment of periodic paroxysmal supraventricular tachycardia (PSVT). Nurses should teach patients to treat symptoms of PSVT with etripamil immediately, and how to administer the nasal spray dosage.

Authors

Diane S. Aschenbrenner

Institutions

Johns Hopkins University (US)
The Dialogue (US)

Publication Details

Journal: AJN American Journal of Nursing
Published: 2026-03-26
DOI: https://doi.org/10.1097/ajn.0000000000000276a
Primary Topic: Cardiac Arrhythmias and Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Calcium channel blocker nasal spray treats paroxysmal supraventricular tachycardia

Diane S. Aschenbrenner

Mar 26, 2026

AJN American Journal of Nursing

Cardiac Arrhythmias and Treatments

article

Calcium channel blocker nasal spray treats paroxysmal supraventricular tachycardia

Diane S. Aschenbrenner

March 26, 2026article en

Abstract

AJN American Journal of NursingVol. 126(4)

Johns Hopkins University (US), The Dialogue (US)

Openalex Percentile: Top 17%

Cardiac Arrhythmias and Treatments

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Calcium channel blocker nasal spray treats paroxysmal supraventricular tachycardia — Diane S. Aschenbrenner · AJN American Journal of Nursing (2026) | TGRS Research Map | TGRS